Full Agenda

Wednesday, March 23, 2022

8:00-9:30 am

1. Fundamentals of Medicare Parts A-D (not repeated)
Stephanie M. Hoffmann, Alison Hollender, Kathryn A. Roe

• Medicare governance and structure – CMS, MACs, and private health plans under Parts A-D
• Beneficiary coverage and benefits and provider payment under Parts A-D
• Provider enrollment and certification under Parts A and B
• Private health plan application and selection under Parts C and D
• Conditions of participation and payment for Parts A and B
• Managed care regulation under Parts C and D
• Transactions, demonstrations, and contracting
• Agency guidance and key compliance resources

2. Year In Review (not repeated)
R. Ross Burris, Hilary Isacson
This session will review top Medicare/Medicaid reimbursement changes in 2021 including:

• The lingering effects of the continuing Public Health Emergency on providers
• Confusing rules about coverage for COVID testing, variation between state and federal rules
• State and federal government efforts to control healthcare prices and protect consumers through price transparency 
• Developments in value-based payment models affecting provider operations
• Coming into compliance with the No Surprises Act & surprise billing regulations among various states
• Provider relief funding reporting and enforcement developments
• Other Medicare reimbursement/enforcement developments

3. The Changing Medicaid Program - A Panel of State Medicaid Directors (not repeated)
Michael H. Cook
Karen Kimsey
Jay Ludlam
Allison L. Taylor
A panel of State Medicaid Directors will:

• How the Medicaid program is changing in a particular state and nationally
• Innovative features of the particular State’s Medicaid program potentially addressing such items as social determinants of health (SDOH), health equity, managed care organizations, the opiod crisis, behavioral health, expansion, APMs, long term care and home and community based care, and 1332 and 1115 waivers
• How COVID is affecting their various programs assuming the pandemic is still a significant issue, and potentially what types of actions the state is taking to prepare for future pandemics

10:00 am-12:00 pm | GENERAL SESSION

Welcome and Program Overview
Cynthia Y. Reisz, Emily J. Cook, Andrew D. Ruskin

General Counsel Corner
Daniel Barry, Gregory E. Demske

Patient Centric Medicare and Medicaid Payment: The Unified Vision
Jon Blum
Emily J. Cook (Moderator), Andrew D. Ruskin (Moderator)

1:15-2:30 pm | Extended Sessions

7. Introduction to Medical Coding for Payment Lawyers (not repeated)
Michael D. Miscoe, Robert A. Pelaia

• The basics of procedural (CPT) and diagnosis (ICD-10) coding
• General guidance on use of the CPT and ICD-10 coding manuals
• Common issues associated with coding billing disputes
• Common legal/compliance issues based on coding

8. Advancing Accountability and Equity through Payment and Care Delivery (not repeated)
Sara Cooperrider, Margia Corner, Erin Estey Hertzog

• The transformation of the US health care system is at an inflection point–Medicare, Medicaid and other payers are starting to hold providers truly accountable for the cost and quality of their care. These same payers and others acknowledge equity is a critical element of high-quality care
• Key developments in holding providers more accountable for the care they provide, including the CMS Innovation Center’s Direct Contracting Model and similar Medicaid and private-payer initiatives
• Nascent efforts by payers to promote health equity through payment and service delivery initiatives
• Common legal issues that arise in structuring participation in initiatives that involve taking on greater accountability for cost and quality and promoting health equity, including:
  • Governance requirements
  • Financial arrangements (e.g., distribution of shared savings)
  • Patient engagement incentives
  • Data sharing and performance measurement
  • Quality reporting and stratifying by race, ethnicity and other social risk factors
  • Safeguards against stinting on medically necessary care, cherry picking, or otherwise steering patients
  • State law considerations (e.g., insurance licensure requirements, patient notice requirements, prohibition against corporate practice of medicine)

9. What Is an Overpayment Really? Overpayment Investigations, Refunds, and False Claims Act Exposure In the Wake of Escobar
Susan J.  Banks, B. Scott McBride

• A provider’s/supplier’s “report and return” obligations under the federal Overpayments Statute, as interpreted by CMS, including its intersection with the federal civil False Claims Act
• Implications of UnitedHealthcare Ins. Co. vs. Azar and implications for when a provider may be deemed to have “identified” an overpayment under the Overpayment Statute
• Criteria for identifying Medicare conditions of payment, which result in overpayments if violated, including the relevance and significance of the “materiality” standard adopted in Universal Health Services v. US ex rel. Escobar in the False Claims Act context
• The Escobar “materiality” standard as it has been interpreted and applied in the Medicare context by federal courts in progeny cases
• Consideration of the potential relevance in the overpayments context of the 2019 US Supreme Court decisions in Kisor v. Wilkie, in which the Court articulated certain guardrails around deference afforded to agency interpretations of its own regulations, and Azar v. Allina Health Services, which affirms a rigorous notice-and-comment requirement under the Medicare statute for rules affecting a substantive legal standard
• Challenges involved in determining what constitutes “credible information” of a potential overpayment and the scope of providers’ duty of “reasonable diligence” under the Overpayments Statute

10. The Changing Face of the Medicaid Program: A Review of Recent Trends in State Medicaid Waivers
Leonardo Cuello, Ross D. Margulies, Marybeth Musumeci

• History and background of the Medicaid waiver process, as well as the current rules and constructs for waiver submissions
• A comprehensive review of recent key State waiver requests and waiver approvals under the Biden Administration
• Key policy and legal issues raised in light of recent waiver approvals by CMS
• What to look for under the Biden Administration–policy updates, guidance, and priorities

11. Provider-Based Status, Under Arrangements, Enrollment, and Related Medicare Requirements
Andrew D. Ruskin, Lawrence W. Vernaglia, David R. Wright

• Provider-based fundamentals
• Current reimbursement issues, including preserving excepted status, site neutrality policy continuation, and 340B drug payment reduction
• Co-location Final Guidance
• Infection control issues relating to space configuration
• Preparing for an end to the Public Health Emergency

3:00-4:00 pm

12. Medicaid State of Mind–Fundamentals of America’s Most Critical Coverage Source (not repeated)
Caroline L. Farrell, Jeff J. Wurzburg

• A brief history of the Medicaid program and its program objectives
• The statutory requirements for Medicaid programs
• The ongoing and critical impact of the Medicaid program during the COVID-19 pandemic
• Different state approaches to Medicaid and Medicaid eligibility
• The future of the Medicaid

13. The Biden Health Policy Agenda in 2022: What to Expect (not repeated)
Eric Zimmerman
The new President has a long health care policy wish list. Tackling COVID remains his top priority, but his signature Build Back Better legislation is a close second. The President and Democratic Congress will be racing to enact as much as possible before mid-term elections later this year. This session will identify anticipated federal Medicare and Medicaid policy changes in 2022 and beyond, and assess how those changes could affect client strategies, budgets and transactions. Top priorities include:

• Telehealth expansions and waivers
• Surprise billing regulations
• Affordable Care Act expansion
• Medicaid waivers
• Drug pricing

14. Promoting Health Equity through the Medicaid Program
Josh Greenberg

• ACOs/health system reform from a child health perspective
• BH
• (Emerging) equity issues
  • Medically complex children
  • Race/ethnicity
• Health equity concerns

15. Medicare Litigation Update
Mimi H. Brouillette, Melissa Hart

• Past year’s significant Medicare reimbursement decisions issued by the federal courts as well as review of the relevant agency decisions at issue
• Litigation topics including: Jurisdiction; scope of the administrative record; substantive and procedural challenges (e.g., notice and opportunity to comment, contrary to law, and arbitrary and capricious); and remedies (e.g., remand orders and injunctions)
• Potential areas of future Medicare litigation implicated by the past year’s developments
• How courts and the agency have addressed the full spectrum of issues that might be applicable in Medicare litigation, thus giving attendees a better understanding of the strengths and weaknesses of ongoing reimbursement issues

16. Just When You Thought You Knew all the Acronyms: 340B Program Overview and Trending Topics
Amanda Nagrotsky, Barbara S. Williams

• The 340B drug discount program and compliance issues
• Issues to be addressed will include: Covered entity eligibility, definition of “patient” for 340B, election to use 340B drugs for Medicaid patients and avoiding “duplicate discounts” for Medicaid FFS and MCO drugs, recent trends in HRSA audit findings, GPO and orphan drug prohibitions, trends in State legislation related to 340B pricing
• Registration of outpatient sites and the importance of the Medicare cost report
• “Hot topics” in the 340B program, including recent litigation contesting manufacturer actions related to the 340B contract pharmacy program

4:30-5:30 pm

17. Medicare and Medicaid: A View from the Hill​ (not repeated)
Stuart Portman

• An overview of legislative activity in the U.S. Congress
• Recent policies affecting Medicaid will be reviewed and future priorities
• Comments may also address upcoming potential legal issues in the Medicaid program

18. Original Medicare DSH Payment (not repeated)
Stephanie Ann Webster

• DSH payment adjustment
• Legal issues, including:
• Medicare Part C days
• Medicare Part A non-covered days
• Section 1115 waiver days
• Jurisdictional challenges/decisions and implications

19. Medicare Graduate Medical Education Reimbursement: Overview and Recent Policy Changes
Tim Johnson, Lori Mihalich-Levin

• Medicare payments for graduate medical education
• In-depth review of new CMS regulations promulgated to implement GME-related sections of Consolidated Appropriations Act
• GME-related sections of Build Back Better Act
• Direct GME "fellows penalty" litigation and next steps

20. Federal Physician Self-Referral Law: Applying the Most Current Regulations and Guidance
Danielle Sloane, Lisa O. Wilson
This advanced session will focus on applying recent changes to the regulations interpreting the Federal Physician Self-Referral Law. The speakers will explain and apply the regulations and guidance using hypotheticals depicting common compliance challenges. This session will:

• Apply new and revised definitions and standards, such as what qualifies as an indirect compensation arrangement, how to apply the new “volume or value” special rules, and more
• Help attendees utilize new and added flexibilities (for example, reconciling payment discrepancies, satisfying writing and signature requirements, and the new exception for limited remuneration to a physician) to mitigate common compliance challenges
• Evaluate CMS’ most recent advisory opinion related to structuring group practices and its implications for group practices generally
• Provide tips for structuring an arrangement to qualify for the new value-based exceptions

21. Telemedicine Reimbursement and Compliance Challenges: COVID and Post COVID
Haider D. Andazola, Marti Arvin

• How the COVID-19 pandemic transformed telehealth
• What are the key reimbursement questions for telehealth post-pandemic
• How the digital revolution is affecting traditional telehealth
• The myriad of issues that can go wrong and create risk when providing telemedicine services
• What are some of the hot spots that OIG is looking at related to telemedicine billing during the PHE
• What should health care organizations anticipate regarding telemedicine compliance post-COVID

Thursday, March 24, 2022

8:15-9:30 am | Extended Sessions

22. Hot Topics in Provider Enrollment: Where are We? (not repeated)
Louise M. Joy, Emily W. Towey, Jeanne L. Vance

• Updates to the Enrollment Chapters of the Medicare Program Integrity Manual-Where did it go?
• Medicare Enrollment in the time of COVID-19-What now?
• Medicare Enrollment Appeal Trends—Meanwhile at the DAB
• Maintaining Medicare Enrollment Compliance—Planting and weeding the “Garden”

23. Current and Emerging Issues in Rural Medicare Policy (not repeated)
Ing-Jye Cheng, Benjamin C. Fee, Darci L. Graves, Sarah Heppner

• Why rural providers and the policies that apply to them have implications for a broader audience
• Recent updates/changes to rural provider payments–including payment changes and flexibilities related to the COVID-19 Public Health Emergency
• Emerging regulatory issues as they relate to rural health care providers
• Recent and forthcoming changes to geographic eligibility for rural health grant programs and future rural funding opportunities
• Recent research into rural care delivery models

24. Hospital Inpatient Prospective Payment Systems Update (not repeated)
Emily Forrest, Marc Hartstein, Katrina Pagonis

• Changes to Payment Rates under IPPS
• Use of Pre-Covid Data to Set Rates for 2022
• Repeal of the Market-Based MS-DRG Relative Weight Policy
• Wage Index Policies
• Medicare DSH
• Empire vs. Becerra
• Medicaid Remittance Advice to Claim Medicare Bad Debt
• COVID-19 Updates

25. How Much Deference Do Courts Give to CMS These Days
Sven C. Collins, Joel L. McElvain

Recent Supreme Court decisions have altered the deference standards courts apply to agency actions, and current cases on appeal present the possibility for even more change. This session will explore:

• How those deference standards are playing out in the lower courts
• What implications those deference standards have for providers and CMS
• Which types of agency actions and circumstances are getting deference and which are not
• How guidance on policymaking practices has been adapted to the new deference standards

26. CMS/OIG Administrative Enforcement: Case Study/CARES Provider Relief Reporting and Audit Defense
Julie Burns, Joseph V. Geraci, Kirk Sripinyo, Judith A. Waltz

Administrative Enforcement: Case Study

• New authorities and focus for COVID-19 Fraud
• CMS–Revocations of Enrollment and Collateral Consequences (No CMS Policy Issues Will Be Discussed)
• OIG–CMP Authorities, Exclusion, and the Role of the Fraud Risk Indicator
• Provider Relief Funds–OIG Audits and Elements Triggering further Investigations
• No CMS policy issues will be discussed

Thursday, March 24, 2022 (continued)

10:00-11:00 am

27. Current Issues in Medicaid Supplemental Payments and Financing (not repeated)
Barbara D. A. Eyman, Charles A. Luband

• Medicaid disproportionate share hospital (DSH) and other Medicaid non-DSH supplemental payments
• Medicaid managed care directed payments
• Medicaid waiver payments, including uncompensated care payments and delivery system reform incentive program payments
• Medicaid financing (IGTs, CPEs, and provider taxes)

28. Collaborating in Patient Care: Evolving Roles, Rules, and Realities for Physicians, Nonphysician Practitioners (NPPs) and Auxiliary Personnel (not repeated)
Timothy P. Blanchard

• Shared Visits and Shared Documentation
• “Incident to” and Care Coordination/Management Services
• Special Rules for PT, OT and SLP Services
• The Peculiar Case of MNT and DSMT Services
• Mental Health and Behavioral Health Integration Services

29. It Still Don’t Mean A Thing If It Ain’t Got Jurisdiction: Jurisdictional Issues Arising in Cases Before the Provider Reimbursement Review Board and Federal Courts
Kenneth R Marcus

• Primer on fundamental law
• Jurisdictional Provisions In PRRB Rules 3.1 (effective November 2021)
• Notable Cases In Past Year
• Recurring Jurisdictional Issues (PRRB and Federal Court)

30. Legal Ethics: Attorneys' Use of Emails, Social Media, Texting
Lynn M. Barrett
This panel will explore a lawyer's duty to understand and utilize modern technology in compliance with the ABA's Model Rules' "Three C's": Competence, Communication and Confidentiality.

• The Model Rules require lawyers to be competent, to effectively communicate with clients, and to maintain the confidentiality of information relating to client representation. These concepts will be explored in the context of today's technology, and the following issues will be explored:
  • How technologically competent must a lawyer be?  With the wide-spread use of cloud computing, what must a lawyer know? How has the pandemic affected this?
  • Social Media can be both a tool and a weapon that lawyers use when representing clients. What are some of the uses of and common pitfalls associated with a lawyer's use of social media?
  • How has a lawyer's use of modern technology affected the confidentiality of client communications? How many times has a lawyer accidentally hit "reply all" when attempting to communicate only with his or her client?
  • Texting can be lead to untoward outcomes, particularly in the context of litigation. What are some of the issues that arise when a lawyer communicates via text?

31. Hot Topics in Fraud and Abuse
Robert Kaufman, Laura Laemmle-Weidenfeld, Lisa Re, Augustine M. Ripa

• Recent developments in CMS’s program integrity efforts
• Recent priorities and developments in HHS-OIG enforcement efforts
• Recent enforcement

11:30 am-12:30 pm

32. Medicare Changes of Ownership (CHOWs) (not repeated)
Darlene Davis, Judy Wong Strobos

• CHOW situations and their impact, including transaction structures
• Benefits and burdens of accepting v. rejecting automatic assignment of the Medicare provider agreement
• Provider transaction scenarios–Medicare Form-CMS 855A perspective
• Change of ownership situations involving non-certified suppliers

33. Medicare and Medicaid Managed Care: Reimbursement and Program Integrity Challenges (not repeated)
Anthony H. Choe, Megan Tinker

• OIG update on enforcement priorities and activities
• CMS policy updates (e.g., rulemaking, draft rate notice and call letter, other guidance)
• MA program oversight of plans and providers
• Plan-provider trends (e.g., reimbursement, contracting)
• Potential for further changes

34. Can the Physician Fee Schedule Be Saved? Updates And The Road Ahead for the Medicare Physician Fee Schedule and Quality Payment Program
Cynthia Brown, Sidney S. Welch

• Important updates and implications from the 2022 Final Physician Fee Schedule
• Trends and considerations for Part B reimbursement
• Looking forward to 2022 and beyond

15. Medicare Litigation Update (repeat)
Mimi H. Brouillette, Melissa Hart

20. Federal Physician Self-Referral Law: Applying the Most Current Regulations and Guidance (repeat)
Danielle Sloane, Lisa O. Wilson

1:45-2:45 pm

35. PRRB Appeals–The View from the Board Chair (not repeated)
Clayton J. Nix

• Introduction of Board members
• Board decisions
• Jurisdiction
• Hearings
• Case inventory
• Board initiatives
• Mandatory electronic filing and case tracking
• Evaluation of decision process
• Observations from the Board

36. Medicaid Litigation (not repeated)
Garrett F. Mannchen, Felicia Y. Sze

• Litigation involving Medicaid waivers and supplemental payments
• Fee-for-service rate litigation
• Managed care litigation, including the authority to implement Medicaid managed care programs, the oversight of those programs, contracting, and provider relations
• Medicaid benefits, including coverage of pediatric behavioral health services and gender reassignment surgeries

14. Promoting Health Equity through the Medicaid Program (repeat)
Josh Greenberg

21. Telemedicine Reimbursement and Compliance Challenges: COVID and Post COVID (repeat)
Haider D. Andazola, Marti Arvin

29. It Still Don’t Mean A Thing If It Ain’t Got Jurisdiction: Jurisdictional Issues Arising in Cases Before the Provider Reimbursement Review Board and Federal Courts (repeat)
Kenneth R Marcus

3:15-4:30 pm | Extended Sessions

37. Medicare Appeals: Soup to Nuts (not repeated)
Hon. McArthur Allen, Meaghan A. Moriarty, Andrew Wachler

• In-depth explanation of the appeals process, what triggers the process, what to expect at each stage, and how to help your clients prepare
• Strategic approaches and practical tips offered by experienced counsel, in house and private practice, and within the ALJ process to consider and implement when appealing overpayment demands and claim denials
• Agency overview and workload updates from OMHA’s Chief Administrative Law Judge
• Recent Developments: Resumption of Targeted Probe and Educate, provider relief fund audits and telemedicine audits
• Additional funding for increased audits and contractor participation in ALJ hearings
• Case Studies

38. Hospital Outpatient Prospective Payment Systems Update (not repeated)
Valerie Rinkle

• Changes to OPPS Payment Rates including use of 2019 Pre-Covid Data to Set Rates for 2022
• Telemedicine for hospitals and RHCs/FQHCs
• Rural Emergency Hospitals
• Changes to the Inpatient Only List and 2-Midnight Rule
• 340B Drug Policies
• Hospital Price Transparency

39. Measuring Changes to Uncompensated Care DSH
Fred A. Fisher, K. Michael Nichols, Mark Polston

• The phenomenon of increasing uncompensated care (UC) costs with decreasing federal payments
• The impact of COVID-19 and UC DSH payments through evaluating clusters of UC costs across country before and during the public health emergency
• Updates to CMS' proposed draft Transmittal 17 cost reporting instructions for reporting UC costs on Worksheet S-10
• Current findings and observations from another year (FFY 2019) of Worksheet S-10 audits

9. What Is an Overpayment Really? Overpayment Investigations, Refunds, and False Claims Act Exposure In the Wake of Escobar (repeat)
Susan J. Banks, B. Scott McBride

25. How Much Deference Do Courts Give to CMS These Days (repeat)
Sven C. Collins, Joel L. McElvain

Friday, March 25, 2022

8:00-9:15 am | Extended Sessions

40. PRRB Appeals: Current Topics (not repeated)
Christine Blowers, Leslie Demaree Goldsmith, Lisa Ogilvie-Barr

• OH CDMS overview and updates
• PRRB Rules 3.1, effective 11/1/21
• Jurisdictional, procedural, and case management concerns
• Avoiding pitfalls and applying best practices before the Board
• Emerging trends

10. The Changing Face of the Medicaid Program: A Review of Recent Trends in State Medicaid Waivers (repeat)
Leonardo Cuello, Ross D. Margulies, Marybeth Musumeci

11. Provider-Based Status, Under Arrangements, Enrollment, and Related Medicare Requirements (repeat)
Andrew D. Ruskin, Lawrence W. Vernaglia

26. CMS/OIG Administrative Enforcement: Case Study/CARES Provider Relief Reporting and Audit Defense (repeat)
Julie Burns, Joseph Geraci, Kirk Sripinyo, Judith A. Waltz

39. Measuring Changes to Uncompensated Care DSH (repeat)
Fred A. Fisher, K. Michael Nichols, Mark Polston

9:45-10:45 am

16. Just When You Thought You Knew all the Acronyms: 340B Program Overview and Trending Topics (repeat)
Amanda Nagrotsky, Barbara S. Williams

19. Medicare Graduate Medical Education Reimbursement: Overview and Recent Policy Changes (repeat)
Tim Johnson, Lori Mihalich-Levin

30. Legal Ethics: Attorneys' Use of Emails, Social Media, Texting (repeat)
Lynn M. Barrett

31. Hot Topics in Fraud and Abuse (repeat)
Robert Kaufman, Laura Laemmle-Weidenfeld, Lisa Re, Augustine M. Ripa

34. Can the Physician Fee Schedule Be Saved? Updates And The Road Ahead for the Medicare Physician Fee Schedule and Quality Payment Program (repeat)
Cynthia Brown, Sidney S. Welch

11:15-11:45 am

41. Diagnostic Imaging Update (not repeated)
Thomas W. Greeson

• Diagnostic imaging in a post-COVID world
• The broken Medicare Physician Fee Schedule payment system's ongoing cuts in payments for physician services
• Full implementation of required consultation of appropriate use criteria when ordering advanced diagnostic imaging expected in 2023
• Barriers to the use of mid-level extenders in radiology–the challenges of state scope of practice rules that do not permit what Medicare allows
• Will virtual supervision of diagnostic tests continue post public health emergency?

42. 340B Program Medicaid/Medicare Reimbursement Issues
Emily J. Cook

• Differences between 340B Program compliance (e.g., 42 USC 256b) and 340B reimbursement compliance (e.g., federal health care program payments and state Medicaid laws)
• State Medicaid 340B reimbursement landscape
• State Medicaid 340B enforcement (California Medi-Cal self-audits)
• Medicare 340B reimbursement changes
• Medicare 340B litigation

43. Clinical Lab Update: What Happened in 2021 and Where Things are Headed in 2022
Jesse Berg
This session will review a range of key developments in clinical lab and pathology over the past year.  Items to be covered include the following:

• Level set about roles of CMS, FDA, CDC and state agencies in regulating clinical lab industry and how things have changed as a result of the Covid pandemic, including review of key CLIA concepts, such as proficiency testing, testing in novel settings like schools and workplaces, growth of direct-to-consumer testing as well as discussion of status and future of lab-specific flexibilities implemented during Public Health Emergency
• Where things stand with laboratory developed tests, including Trump and Biden Administration approaches, review of VALID Act and other potential legislative fixes and varying HHS directives on FDA regulation of LDTs
• PAMA reporting obligations, implications of delay in PAMA requirements resulting from Public Health Emergency and how PAMA affects Clinical Lab Fee Schedule
• Trend of ever-increasing restrictions on reimbursement, coverage and operations imposed by commercial payors on clinical lab and pathology industry
• Clinical lab enforcement activities in 2021-2022, including traditional (False Claims Act, Anti-kickback Statute, interesting CLIA initiatives, failure to have orders / medical necessity) and novel (EKRA, FDA actions related to test performance, labeling and advertising, CMS actions to close labs due to Covid testing performance, genomic testing fraud) developments
• Other interesting laboratory concepts, such as co-location restrictions and how shared laboratories are treated under CLIA and Medicare principles

44. Remote Monitoring Services: Making Sense of RPM, RTM, and Beyond
Jacob Harper, Carol Yarbrough

• CMS's implementation of RPM service coverage in Medicare and whether providers have been able to successfully bill for these services
• What are the barriers to fulsome RPM adoption?
• How is RTM different from RPM and why did AMA and CMS decide to implement a second series of codes
• Case studies on how various providers are utilizing RPM or RTM services

12:00-12:30 pm

45. New Technology Reimbursement: Spotlight on Inpatient and Outpatient Cell Therapies Including CAR-T (not repeated)
Scott R. Bezjak

• Recent changes to forms and regulations for organ transplants, bone marrow transplants and CAR T-Cell therapies
• Walk-through applicable Medicare cost report forms and reporting requirements for organ transplants, bone marrow transplants and CAR T-Cell therapies
• Medicare and Medicaid reimbursement strategies related to organ transplants, bone marrow transplants and CAR T-Cell therapies
• Compliance strategies related to Medicare cost reporting for organ transplants, bone marrow transplants and CAR T-Cell therapies

42. 340B Program Medicaid/Medicare Reimbursement Issues (repeat)
Emily J. Cook

43. Clinical Lab Update: What Happened in 2021 and Where Things are Headed in 2022 (repeat)
Jesse Berg

44. Remote Monitoring Services: Making Sense of RPM, RTM, and Beyond (repeat)
Jacob Harper, Carol Yarbrough